Novel roles of the tumor microenvironment have introduced in regulating drug resistance, and macrophages in microenvironment have been proposed as factors contributing to the resistances of PI3K inhibitors through the activation of NF-κB signaling [211]. Here, PIK3CG is linked to neoplasm.